In the study, "Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration," published in JAMA Ophthalmology, researchers conducted a population-based ...
Please provide your email address to receive an email when new articles are posted on . GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results